Yazar "Altundag, K." seçeneğine göre listele
Listeleniyor 1 - 2 / 2
Sayfa Başına Sonuç
Sıralama seçenekleri
Öğe Nine versus 52 weeks of adjuvant trastuzumab in early breast cancer: An observational study of the Turkish Oncology Group.(Amer Soc Clinical Oncology, 2011) Icli, F.; Altundag, K.; Coskun, U.; Paydas, S.; Basaran, G.; Saip, P.; Dogu, G. G.[Abstract Not Available]Öğe Outcome of 561 non-metastatic triple negative breast cancer patients: Multi-center experience from Turkey(Elsevier Sci Ltd, 2013) Budakoglu, B.; Altundag, K.; Berk, V.; Ozkan, M.; Algin, E.; Dogu, G. G.; Harputluoglu, H.[Abstract Not Available]
